Latest Shareholder Activism News

Percheron Therapeutics has discontinued its ATL1103 program and curtailed investment in ATL1102 following underwhelming trial results, while advancing talks to in-license new rare disease therapies and extending its cash runway into FY2027.

Clara Resources outlines key progress on its Ashford Coking Coal Project drilling preparations and details ongoing capital management initiatives, including rights issues and entitlement offers, while navigating boardroom challenges.

The Takeovers Panel has declined to investigate Global Lithium Resources Limited's claims of undisclosed shareholder associations ahead of its AGM, citing untimeliness and lack of merit.